NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

A DOAC Deep Dive: Edoxaban

For the past several decades, warfarin has been the go-to anticoagulant (blood thinner) for doctors, but new treatments have recently…

Clot Chronicles: The MARINER Trial

Dr. Sam Goldhaber discusses the results of the MARINER trial. As an added bonus, Dr. James Welker provides his commentary.…